Xencor | Brutto Fortjeneste På Salg



Gross Profit On Sales Endring Dato
AbbVie USD 10.71B 458M 2024-12
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Amgen USD 5.54B 430M 2025-03
Arrowhead Research -173085000 2.55M 2024-12
AstraZeneca USD 11.35B 819M 2025-03
Biogen USD 1.87B 44.1M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Cytokinetics -160545000 81.19M 2024-09
GlaxoSmithKline GBP 5.59B 34M 2025-03
J&J USD 14.6B 816M 2025-03
MacroGenics USD 13.86M 94.98M 2024-12
Merck USD 12.77B 849M 2025-03
Novartis USD 10.23B 294M 2024-12
Pfizer USD 11.12B 987M 2025-03
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Xencor -45143000 40.69M 2024-09



Xencor Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.